tag:blogger.com,1999:blog-7857054149675424609.post7235160336223413903..comments2024-02-24T08:58:08.581+00:00Comments on RNAi Therapeutics: 2 Short Stories: An siRNA Delivery Paper by Merck, Pharmaceutical Interest in Silence’s Gene TargetDirk Hausseckerhttp://www.blogger.com/profile/18320439857875629714noreply@blogger.comBlogger6125tag:blogger.com,1999:blog-7857054149675424609.post-4774076410256574802010-10-23T05:52:51.472+00:002010-10-23T05:52:51.472+00:00Thanks, Anita, you are right, of course. I will co...Thanks, Anita, you are right, of course. I will correct it.Dirk Hausseckerhttps://www.blogger.com/profile/18320439857875629714noreply@blogger.comtag:blogger.com,1999:blog-7857054149675424609.post-40425718755041160382010-10-22T16:58:58.274+00:002010-10-22T16:58:58.274+00:00I wanted to state a correction. The Zamore design...I wanted to state a correction. The Zamore design rules patents are licensed to Silence (Intradigm), not assigned.<br /><br />Thank you.Anita Ballesterosnoreply@blogger.comtag:blogger.com,1999:blog-7857054149675424609.post-15341987737637289002010-10-21T02:54:16.555+00:002010-10-21T02:54:16.555+00:00Nothing new on the listing as far as I know. My h...Nothing new on the listing as far as I know. My hope naturally is, also because the timing is right given the dynamics in the space (Novartis, RNAi trigger IP situation clarifying), that the delay would be due to the Company exploring 'listing alternatives'.Dirk Hausseckerhttps://www.blogger.com/profile/18320439857875629714noreply@blogger.comtag:blogger.com,1999:blog-7857054149675424609.post-24665799038268958442010-10-20T15:31:18.255+00:002010-10-20T15:31:18.255+00:00Dirk, how big an upside do you think Tekmira could...Dirk, how big an upside do you think Tekmira could realize simply by being listed on the NASDAQ? Currently, the company experiences little volume on the TSX.<br /><br />TKM previously said they'd be listed Sept-Oct. Have you heard anything new regarding this?Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-7857054149675424609.post-52853166363029055182010-10-19T17:09:13.171+00:002010-10-19T17:09:13.171+00:00RR- Thanks, I was aware of this relationship, but ...RR- Thanks, I was aware of this relationship, but out of privacy concerns chose to not emphasize it too much. In any case, it will be very interesting to see where Pfizer is going with the PKN3 program...Dirk Hausseckerhttps://www.blogger.com/profile/18320439857875629714noreply@blogger.comtag:blogger.com,1999:blog-7857054149675424609.post-71587438379485264112010-10-19T15:53:33.397+00:002010-10-19T15:53:33.397+00:00Dirk,
Regarding the Wyeth inventor on the PKN3 pa...Dirk,<br /><br />Regarding the Wyeth inventor on the PKN3 patent Anke Klippel-Giese...who is the CSO of Silence? Klaus Giese. Interesting to speculate what relationship between Pfizer and Silence this may foster.<br /><br />Remember that Silence grew out of Atugen, so this paper is very relevant. <br /><br />2004: Leenders Frauke;... Giese Klaus; Kaufmann Jörg; Klippel Anke<br />PKN3 is Anonymousnoreply@blogger.com